Childhood Low Grade Glioma — Trials

Childhood Low Grade Glioma — Trials · CancerIndex

Clinical trials

Registered studies

44 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01089101	Selumetinib in Treating Young Patients With Recurrent or Refractory Low Grade Glioma	active not recruiting	Phase 1 / Phase 2	217	National Cancer Institute (NCI)NIH	1	Sep 21, 2026	clinicaltrials
NCT02359565	Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma	active not recruiting	Phase 1	71	National Cancer Institute (NCI)NIH	2	Jul 20, 2026